Rod Rahimi
banner
rodrahimi.bsky.social
Rod Rahimi
@rodrahimi.bsky.social
Physician-Scientist at Massachusetts General Hospital. Posting about biology (mostly immunology) and medicine

https://www.rahimi-lab.com
Pinned
Hello Friends, I created a 5th #immunology Starter Pack. If you're an immunologist and you don't see yourself on the lists, let me know 🧪

go.bsky.app/PY5tCas

go.bsky.app/FmERUoD

go.bsky.app/6aT6qDS

go.bsky.app/QSEPDoj

go.bsky.app/Mdbpk7h
Friends, it's fun to see the #immunology community continue to grow! I created a 4th Starter Pack to help folks find each other. If you're an immunologist and you don't see yourself on the lists, let me know 🧪

go.bsky.app/PY5tCas

go.bsky.app/FmERUoD

go.bsky.app/6aT6qDS

go.bsky.app/QSEPDoj
Friends, the second #immunology starter pack filled in 3 days! I started a third to help folks new to BlueSky rebuild their network

Below are the links

If you're an immunologist and I have missed you so far, let me know 🧪

go.bsky.app/PY5tCas

go.bsky.app/FmERUoD

go.bsky.app/6aT6qDS
Reposted by Rod Rahimi
This week is particularly remarkable in terms of #CellDeath and infection biology-related discoveries: biomed.news/bims-cediti/...
Highlight 1: SIGLEC12 mediates plasma membrane rupture during necroptotic cell death:
SIGLEC12 mediates plasma membrane rupture during necroptotic cell death - Nature
CRISPR–Cas9-based genome-wide screening shows that SIGLEC12 mediates plasma membrane rupture in cells undergoing necroptosis, possibly through a human-specific mechanism, indicating its potential as a...
www.nature.com
November 16, 2025 at 9:09 AM
Reposted by Rod Rahimi
Just got an email from my SRO for the study section that was missed in October. Good news is that they are trying to reschedule ASAP (Dec/Jan). The bad news is that CSR is mandating that only the the top third (not half) of applications will get discussed for the next 2 rounds.
November 13, 2025 at 10:34 PM
Reposted by Rod Rahimi
Live look at NIH SROs today….
kermit the frog is typing on a typewriter in a messy room .
ALT: kermit the frog is typing on a typewriter in a messy room .
media.tenor.com
November 13, 2025 at 4:36 PM
Reposted by Rod Rahimi
While the government was shut down, 379 NIH study section meetings (containing 24,380 grant applications) were postponed. NIH is committed to getting these reviewed, but please be patient and understanding with staff, as this is a complex and heavy lift.
November 13, 2025 at 1:25 PM
Reposted by Rod Rahimi
www.science.org/doi/10.1126/...

“These EBV-infected B cells with antigen-presenting abilities had the capacity to activate autoreactive helper T cells, setting off a chain reaction where those T cells could activate other autoreactive B cells, including uninfected ones.”

#SLE #Bcell #EBV
Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus
Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells to promote pathogenic antinuclear T and B cell responses in lupus.
www.science.org
November 13, 2025 at 2:46 AM
Reposted by Rod Rahimi
Up to 323 cancelled CSR study sections. That's more than the 204 sections cancelled earlier this year. Rescheduling is going to be a hot mess with NIH staff reductions and study section members heading into finals and holidays that limit availability. 🧪
Been a rough year for federally funded scientists, and I hate to add another tab to this spreadsheet. So far, the shutdown has resulted in cancellation of 161 CSR study sections. 🧪https://docs.google.com/spreadsheets/d/1lLEx14q7HKrlYahQYJaN6aHKpMqSMJwX4aenyL5g_ZU/edit?usp=sharing
2025 Study section tracking
docs.google.com
November 11, 2025 at 9:44 PM
Reposted by Rod Rahimi
My ask of any science enthusiasts who tell the story of Rosalind Franklin:
Don't make her life be about the DNA debacle. She died far too young, but she was a promising scientist in her own right, a mentor and scientific author.

Not for Watson or Crick, but for her legacy.
November 8, 2025 at 2:17 AM
Reposted by Rod Rahimi
And here's a YouTube link. www.youtube.com/watch?v=Oj0P...
"Rovina's Choice" Shows How The Shutdown of U.S.A.I.D. Has Already Killed Hundreds of Thousands
YouTube video by The New Yorker
www.youtube.com
November 6, 2025 at 10:36 PM
Reposted by Rod Rahimi
I helped make a film, out this week, called “Rovina’s Choice,” about the deaths this man without conscience or accountability has caused — already 600,000, ⅔ of them children.
November 6, 2025 at 10:34 PM
Reposted by Rod Rahimi
Multi-Year funding analysis, a 🧵

I have been trying to find a robust way of quantifying and understanding multi-year (forward funding).

First, some background:

Most NIH grants are for multiple years (2 to 5, typically).

However, the are usually funded on an annual basis.

1/18
November 3, 2025 at 5:20 PM
Reposted by Rod Rahimi
Literal insanity that a company that made a product that saved millions of lives just a few years ago could go out of business www.statnews.com/2025/10/30/m...
November 4, 2025 at 4:49 PM
Reposted by Rod Rahimi
Delighted that this study is finally out @embojournal.org. A detailed analysis of how DNGR-1/CLEC9A signals to promote cross-presentation of dead cell-associated antigens yet does not activate dendritic cells.
www.embopress.org/doi/full/10....
DNGR-1 signalling limits dendritic cell activation for optimal antigen cross-presentation | The EMBO Journal
imageimageDNGR-1 (CLEC9A) is a C-type lectin receptor of type-1 conventional dendritic cells (cDC1s) with an important role in cross-presentation of dead cell antigens. This study explores how it equips cDC1s with the ability to cross-present such ...
www.embopress.org
November 3, 2025 at 5:23 PM
Reposted by Rod Rahimi
November 2, 2025 at 10:51 PM
Reposted by Rod Rahimi
'Upon attending a Baltimore scientific group meeting in 1988, at which the cloning of the immunoglobulin recombinase-activating gene RAG1, characterization of (IκB) & critical functional attributes of the c-ABL & BCR/ABL proteins were presented, sabbatical scientist Harold Varmus emerged gobsmacked'
Remembering David Baltimore (1938–2025)
David Baltimore, one of modern biology’s most influential scientists, passed away at his home in Woods Hole, Massachusetts, on September 6, 2025 at the age of 87, leaving legions of former trainees an...
www.cell.com
November 2, 2025 at 5:01 PM
Reposted by Rod Rahimi
#InflammasomePower! 💥New paper alert💥 How is NLPR3 primed & activated in chronic non-communicable inflammatory diseases? With @oceanedufies.bsky.social &co we show that chronic exposure to oxPAPC drives NRF2 activation that primes & activates NLRP3 sustaining #atherosclerosis in mice & humans! 👇👇👇
Chronic sensing of host-derived lipids is an all-in-one signal that primes and activates NLRP3.
Activation of the NLRP3 inflammasome leads to the production of bioactive interleukin (IL)-1β fostering atherosclerosis. The current dogma is that NLRP3 must be first primed by microbial stimuli, know...
www.biorxiv.org
October 31, 2025 at 3:49 PM
“Contrary to the prevailing paradigm of fetal immune quiescence, we uncover widespread memory/activated T cells and tissue-resident memory clones shared across organs, indicating systemic immune activity beyond localized barrier defense.”
October 31, 2025 at 12:27 AM
🧪#Immunology
October 31, 2025 at 12:10 AM
Reposted by Rod Rahimi
I've been asked about this paper (www.nature.com/articles/s41...) enough times that I finally had to read it.

The basic claim is that mRNA vaccines had huge synergistic benefit with checkpoint blockade against lung cancer melanoma.

tl;dr it's glam-slop & everyone involved should be embarrassed
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade - Nature
mRNA vaccines targeting SARS-CoV-2 also sensitize tumours to immune checkpoint inhibitors.
www.nature.com
October 30, 2025 at 3:35 PM
Reposted by Rod Rahimi
Pre-print alert! And this one really is a must read for anyone that does spectral #flowcytometry. It is a complete, fully-automated spectral unmixing pipeline that reduces error up to 9000-fold.

Want to get a tough sample, like lung, looking like this? Read more!

www.biorxiv.org/content/10.1...
October 28, 2025 at 8:06 AM
Reposted by Rod Rahimi
#WeekendRead! #InterferonPower! Lin, Sayour, Grippin &co show @nature.com that SARSCoV2 #mRNAvaccines potentiate in cancer patients & mouse models immune checkpoint blockade anti-tumor therapy thanks to increased type I interferon signaling! www.nature.com/articles/s41...
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade - Nature
mRNA vaccines targeting SARS-CoV-2 also sensitize tumours to immune checkpoint inhibitors.
www.nature.com
October 26, 2025 at 3:28 PM
Such a clever and impactful idea

“And you don’t have to convince people they need it,” she added. “It takes into account the local practices, that people are already wearing their babies and laying them to sleep in the same cloth.”🧪🩺
'There were 66% fewer cases among those children compared with babies in the untreated wraps. By the end of the six-month study, only 16% of children in the treated wrap group had been sick with malaria, compared with 34% in the untreated wrap group, many of whom had multiple malaria episodes'
In Fight Against Malaria, an Unexpected — and Snuggly — Shield
www.nytimes.com
October 26, 2025 at 3:34 PM
Reposted by Rod Rahimi
Enzymatic and autophagic catabolism of lipid droplets after unsaturated fatty acid uptake induces pathogenic TH2 cells @sciimmunology.bsky.social
www.science.org/doi/10.1126/...
October 24, 2025 at 7:09 PM
Reposted by Rod Rahimi
Review @natimmunol.nature.com
Antigen-presenting cells as arbiters of mucosal tolerance and immunity
www.nature.com/articles/s41...
October 17, 2025 at 5:10 PM